Loeillot Olivier bought RGEN
February 27, 2024 · Form 4 insider transaction
Loeillot Olivier bought 2,860 shares of Repligen Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,860
Price
$0.00
Total value
N/A
InsiderLoeillot Olivier
RoleOfficer, Director
CompanyRepligen Corporation (RGEN)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2024
Filing dateFebruary 29, 2024
Shares owned after2,860
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One third of the stock options will vest and become exercisable annually on February 27, 2025, February 27, 2026 and February 27, 2027.